Other substances

N-(1,3-Benzodioxol-5-ylmethyl)-6H-indolo[2,3-b]quinoxaline-2-carboxamide

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

N-(1,3-Benzodioxol-5-ylmethyl)-6H-indolo[2,3-b]quinoxaline-2-carboxamide on PubChem

Synonyms

CP-25; ZINC6757463; ZINC000006757463

 

Structure image - N-(1,3-Benzodioxol-5-ylmethyl)-6H-indolo[2,3-b]quinoxaline-2-carboxamide

C1OC2=C(O1)C=C(C=C2)CNC(=O)C3=CC4=C(C=C3)N=C5C(=N4)C6=CC=CC=C6N5


 

Supporting references

Link Tested on Impact factor Notes Publication date
Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
3CLpro Small molecule In silico 		in silico 2.57

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Dec/04/2020
Export (.csv)